A comprehensive and coordinated effort to accelerate our understanding of the molecular basis of cancer through the application of genome analysis technologies, including large-scale genome sequencing.
The program provides detailed genetic and molecular information on various cancers, including hematologic malignancies, and it allows users to analyze genomic data, mutation profiles, and expression patterns across different cancers.
Batch Entrez is a tool provided by NCBI that allows users to retrieve large sets of biological data, such as genetic sequences or protein information, by submitting a list of accession numbers or identifiers. This batch processing capability streamlines the retrieval of multiple records from NCBI databases.
The Genome Data Viewer (GDV) is a powerful genome browser designed to support the exploration and analysis of annotated genome assemblies. It provides access to both NCBI-annotated and submitter-annotated eukaryotic genome assemblies, including data from over 3,000 organisms. It enables the visualization of a wide range of genomic data, including gene annotations, sequence variations, and experimental data from sources like GEO and dbGaP.
Includes a database of known genes, their genomic context, functional annotations, and related research. It provides insights into gene expression, mutations, and associated diseases, including many related to hematologic malignancies.
Useful for exploring gene mutations and variants linked to hematologic cancers like MPNs, leukemias, and lymphomas.
Includes a database of known genes, their genomic context, functional annotations, and related research. It provides insights into gene expression, mutations, and associated diseases, including many related to hematologic malignancies.
Useful for exploring gene mutations and variants linked to hematologic cancers like MPNs, leukemias, and lymphomas.
The Genetic Testing Registry (GTR®) provides a central location for voluntary submission of genetic test information by providers. The scope includes the test's purpose, methodology, validity, evidence of the test's usefulness, and laboratory contacts and credentials. The overarching goal of the GTR is to advance the public health and research into the genetic basis of health and disease.